Literature DB >> 1649192

Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.

H Watanabe1, P Carmi, V Hogan, T Raz, S Silletti, I R Nabi, A Raz.   

Abstract

Tumor autocrine motility factor (AMF) has been detected in and purified from serum-free conditioned medium of human HT-1080 fibrosarcoma cells. Under nonreducing conditions, AMF migrates in sodium dodecyl sulfate-polyacrylamide gel electrophoresis as a single band of 55 kDa but under reducing conditions as a band of 64 kDa. Two-dimensional polyacrylamide gel electrophoresis of the purified AMF resolved two groups of polypeptides with isoelectric points of 6.1 and 6.2 (majors), 6.35 and 6.4 (minors). Purified AMF stimulated HT-1080 cell migration in a dose-dependent fashion. The motility stimulation of the fibrosarcoma cells with AMF is associated with the phosphorylation of the AMF receptor, a 78-kDa cell surface glycoprotein (gp78), suggesting protein kinase participation in migratory signal transduction. The gene encoding gp78 was cloned from an HT-1080 fibrosarcoma complementary DNA library. The deduced sequence encodes a polypeptide of 323 amino acids. The nucleotide and predicted amino acid sequence of the gp78 reveals significant homology with the human suppressor/oncogene p53 protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649192

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Moonlighting protein prediction using physico-chemical and evolutional properties via machine learning methods.

Authors:  Farshid Shirafkan; Sajjad Gharaghani; Karim Rahimian; Reza Hasan Sajedi; Javad Zahiri
Journal:  BMC Bioinformatics       Date:  2021-05-24       Impact factor: 3.169

2.  Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia.

Authors:  Masakatsu Hishizawa; Kazunori Imada; Tomomi Sakai; Momoko Nishikori; Nobuyoshi Arima; Mitsuru Tsudo; Takayuki Ishikawa; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

3.  Crystallization and preliminary X-ray characterization of phosphoglucose isomerase from Mycobacterium tuberculosis H37Rv.

Authors:  Divya Mathur; Kanchan Anand; Deepika Mathur; Nirmala Jagadish; Anil Suri; Lalit C Garg
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-03-30

Review 4.  Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation.

Authors:  Zlatka Kostova; Yien Che Tsai; Allan M Weissman
Journal:  Semin Cell Dev Biol       Date:  2007-09-08       Impact factor: 7.727

5.  Structural studies of phosphoglucose isomerase from Mycobacterium tuberculosis H37Rv.

Authors:  Kanchan Anand; Divya Mathur; Avishek Anant; Lalit C Garg
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-04-29

6.  Identification and characterization of motility stimulating factor secreted from pancreatic cancer cells: role in tumor invasion and metastasis.

Authors:  Y Sakurai; T Sawada; Y S Chung; Y Funae; M Sowa
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 7.  Protein moonlighting: what is it, and why is it important?

Authors:  Constance J Jeffery
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

8.  Neural cell adhesion molecule L1 in gliomas: correlation with TGF-beta and p53.

Authors:  T Tsuzuki; S Izumoto; T Ohnishi; S Hiraga; N Arita; T Hayakawa
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

9.  Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma.

Authors:  H Watanabe; K Kanbe; M Chigira
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

10.  A role for LIM kinase in cancer invasion.

Authors:  Kiyoko Yoshioka; Victoria Foletta; Ora Bernard; Kazuyuki Itoh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.